
Sanofi SA
PAR:SAN

Intrinsic Value
The intrinsic value of one
SAN
stock under the Base Case scenario is
122.95
EUR.
Compared to the current market price of 90.71 EUR,
Sanofi SA
is
Undervalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Sanofi SA
Fundamental Analysis


Revenue & Expenses Breakdown
Sanofi SA
Balance Sheet Decomposition
Sanofi SA
Current Assets | 42.3B |
Cash & Short-Term Investments | 7.4B |
Receivables | 439m |
Other Current Assets | 34.4B |
Non-Current Assets | 90.4B |
Long-Term Investments | 12B |
PP&E | 11.6B |
Intangibles | 66.3B |
Other Non-Current Assets | 560m |
Free Cash Flow Analysis
Sanofi SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Sanofi SA
Revenue
|
44.3B
EUR
|
Cost of Revenue
|
-13.2B
EUR
|
Gross Profit
|
31.1B
EUR
|
Operating Expenses
|
-21.6B
EUR
|
Operating Income
|
9.5B
EUR
|
Other Expenses
|
-3.7B
EUR
|
Net Income
|
5.7B
EUR
|
SAN Profitability Score
Profitability Due Diligence
Sanofi SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Score
Sanofi SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
SAN Solvency Score
Solvency Due Diligence
Sanofi SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Score
Sanofi SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SAN Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for
SAN
is 117.84 EUR
with a low forecast of 63.63 EUR and a high forecast of 136.5 EUR.
Dividends
Current shareholder yield for SAN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SAN
stock under the Base Case scenario is
122.95
EUR.
Compared to the current market price of 90.71 EUR,
Sanofi SA
is
Undervalued by 26%.